Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06397885

Prospective on Market Patient-reported Outcomes for Milli

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Materna Medical · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

To assess the effectiveness of the Milli device in achieving vaginal intercourse

Detailed description

The Milli Vaginal Dilator is a patient-controlled vaginal dilator that provides therapy through distention of the vaginal tissue under electromechanical expansion. This study is intended to provide data in support of the Milli Vaginal Dilator as a commercially available, over-the-counter medical device. The Milli has been granted marketing authorization by the FDA under premarket notification K220035 for the following Indications for Use statement: The Milli Vaginal Dilator is a tool indicated for controlled dilation of the vagina. It can be used for dilation for an examination (by your doctor), in preparation for a surgical procedure, or to help relieve the symptoms of vaginismus (condition that involves tightening of the vaginal muscles) and related painful sex. .

Conditions

Interventions

TypeNameDescription
DEVICEMilli Vaginal DilatorPatient-controlled vaginal dilator that provides therapy through distention of the vaginal tissue under electromechanical expansion

Timeline

Start date
2024-05-12
Primary completion
2025-11-30
Completion
2025-12-30
First posted
2024-05-03
Last updated
2024-11-20

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06397885. Inclusion in this directory is not an endorsement.